Metraipolis › archive › dc_bcaf1bd7b37b
Succinylation in cancer immunotherapy: mechanisms, biomarkers, and therapeutic implications — Europe PMC PMID:42183207
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42183207
- DOI
- 10.3389/fimmu.2026.1794817
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-02T14:38:53.764Z
- SHA-256 of the archived text
f3cd042042a6b2d45f39f56f0d524f93143d4e2f027818c617702dfc54576538- Stable URL of this page
https://metraipolis.com/documento/dc_bcaf1bd7b37b
How to cite
Succinylation in cancer immunotherapy: mechanisms, biomarkers, and therapeutic implications — Europe PMC PMID:42183207 — Europe PMC (en), https://europepmc.org/article/MED/42183207 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bcaf1bd7b37b (Metraipolis archive dc_bcaf1bd7b37b, sha256 f3cd042042a6b2d45f39f56f0d524f93143d4e2f027818c617702dfc54576538)
BibTeX
@misc{dcbcaf1bd7b37b,
title = {Succinylation in cancer immunotherapy: mechanisms, biomarkers, and therapeutic implications — Europe PMC PMID:42183207},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42183207},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bcaf1bd7b37b; sha256 f3cd042042a6b2d45f39f56f0d524f93143d4e2f027818c617702dfc54576538},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42183207. Agents can read the archived copy with the MCP tool read_document.